2,271
Views
22
CrossRef citations to date
0
Altmetric
Research Paper

Downregulation of long non-coding RNA LINC00460 inhibits the proliferation, migration and invasion, and promotes apoptosis of pancreatic cancer cells via modulation of the miR-320b/ARF1 axis

, & ORCID Icon
Pages 96-107 | Received 21 Oct 2020, Accepted 08 Dec 2020, Published online: 21 Dec 2020

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.
  • Ando Y, Ohuchida K, Otsubo Y, et al. Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5. PLoS One. 2020;15(1):e0228015.
  • Garcia-Carbonero N, Li W, Cabeza-Morales M, et al. New hope for pancreatic ductal adenocarcinoma treatment targeting endoplasmic reticulum stress response: a systematic review. Int J Mol Sci. 2018;19(9):2468.
  • McGuigan A, Kelly P, Turkington RC, et al. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018;24(43):4846–4861.
  • Huang X, Xiao R, Pan S, et al. Uncovering the roles of long non-coding RNAs in cancer stem cells. J Hematol Oncol. 2017;10(1):62.
  • Wawrzyniak O, Zarﺅﻷbska ﻊ, Rolle K, et al. Circular and long non-coding RNAs and their role in ophthalmologic diseases. Acta Biochim Pol. 2018;65(4):497–508.
  • Chan JJ, Tay Y. Noncoding RNA: RNA regulatory networks in cancer. Int J Mol Sci. 2018;19(5):1310.
  • Wang Y, Li Z, Zheng S, et al. Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers. Oncotarget. 2015;6(34):35684–35698.
  • Wang F, Liang S, Liu X, et al. LINC00460 modulates KDM2A to promote cell proliferation and migration by targeting miR-342-3p in gastric cancer. Onco Targets Ther. 2018;11:6383–6394.
  • Xie X, Xiong G, Wang Q, et al. Long non-coding RNA LINC00460 promotes head and neck squamous cell carcinoma cell progression by sponging miR-612 to up-regulate AKT2. Am J Transl Res. 2019;11(10):6326–6340.
  • Jin J, Xu H, Li W, et al. LINC00346 acts as a competing endogenous RNA regulating development of hepatocellular carcinoma via modulating CDK1/CCNB1 axis. Front Bioeng Biotechnol. 2020;8:54.
  • Dong Y, Quan HY. Downregulated LINC00460 inhibits cell proliferation and promotes cell apoptosis in prostate cancer. Eur Rev Med Pharmacol Sci. 2019;23(14):6070–6078.
  • Sun J, Yang J, Lv K, et al. Long non-coding RNA LINC00460 predicts poor survival and promotes cell viability in pancreatic cancer. Oncol Lett. 2020;20(2):1369–1375.
  • Cai C, Yang L, Tang Y, et al. Prediction of overall survival in gastric cancer using a nine-lncRNA. DNA Cell Biol. 2019;38(9):1005–1012.
  • Zhuang C, Ma Q, Ye J, et al. LncRNA GClnc1 promotes proliferation and invasion of bladder cancer through activation of MYC. Faseb J. 2019;33(10):11045–11059.
  • Jiang Y, Cao W, Wu K, et al. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus. J Exp Clin Cancer Res. 2019;38(1):365.
  • Tu J, Zhao Z, Xu M, et al. LINC00460 promotes hepatocellular carcinoma development through sponging miR-485-5p to up-regulate PAK1. Biomed Pharmacother. 2019;118:109213.
  • Li K, Sun D, Gou Q, et al. Long non-coding RNA linc00460 promotes epithelial-mesenchymal transition and cell migration in lung cancer cells. Cancer Lett. 2018;420:80–90.
  • Lian Y, Yan C, Xu H, et al. A novel lncRNA, LINC00460, affects cell proliferation and apoptosis by regulating KLF2 and CUL4A expression in colorectal cancer. Mol Ther Nucleic Acids. 2018;12:684–697.
  • Li Y, Tang X, He Q, et al. Overexpression of mitochondria mediator gene TRIAP1 by miR-320b loss is associated with progression in nasopharyngeal carcinoma. PLoS Genet. 2016;12(7):e1006183.
  • Lv GY, Miao J, Zhang XL. Long noncoding RNA XIST promotes osteosarcoma progression by targeting Ras-related protein RAP2B via miR-320b. Oncol Res. 2018;26(6):837–846.
  • Cao W, Zhou G. LncRNA SNHG12 contributes proliferation, invasion and epithelial-mesenchymal transition of pancreatic cancer cells by absorbing miRNA-320b. Biosci Rep. 2020;40(6). DOI:10.1042/bsr20200805
  • Jingyang Z, Jinhui C, Lu X, et al. Mir-320b inhibits pancreatic cancer cell proliferation by targeting FOXM1. Curr Pharm Biotechnol. 2020. DOI:10.2174/1389201021999200917144704
  • Davis JE, Xie X, Guo J, et al. ARF1 promotes prostate tumorigenesis via targeting oncogenic MAPK signaling. Oncotarget. 2016;7(26):39834–39845.
  • Gu G, Chen Y, Duan C, et al. Overexpression of ARF1 is associated with cell proliferation and migration through PI3K signal pathway in ovarian cancer. Oncol Rep. 2017;37(3):1511–1520.
  • Xu J, Zhang J. LncRNA TP73-AS1 is a novel regulator in cervical cancer via miR-329-3p/ARF1 axis. J Cell Biochem. 2020;121(1):344–352.
  • Lang L, Shay C, Zhao X, et al. Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics. J Exp Clin Cancer Res. 2017;36(1):112.